Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 3/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 5/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Styrene SCHEMBL19582218 | 0.95 | ALDH1A1 (0.43) | KDM4EHCAR2TSHRL3MBTL1ALDH1A1 | |
| Styrene SCHEMBL9147646 | 0.93 | TDP1 (0.40) | KDM4EHCAR2TDP1TSHRL3MBTL1 | |
| Styrene SCHEMBL6545344 | 0.92 | TSHR (0.40) | KDM4EHCAR2TDP1TSHRL3MBTL1 | |
| Styrene SCHEMBL6556232 | 0.89 | KDM4E (0.47) | KDM4ETDP1TSHRL3MBTL1ALDH1A1 | |
| Styrene SCHEMBL8175798 | 0.89 | ALDH1A1 (0.39) | KDM4EHCAR2TSHRL3MBTL1ALDH1A1 | |
| Styrene SCHEMBL15510410 | 0.88 | THRB (0.52) | KDM4EHCAR2TDP1TSHRAPP | |
| Styrene SCHEMBL10829930 | 0.87 | TSHR (0.43) | KDM4EHCAR2TDP1TSHRL3MBTL1 | |
| Styrene SCHEMBL4453476 | 0.86 | HCAR2 (0.43) | KDM4EHCAR2TDP1TSHRL3MBTL1 | |
| SCHEMBL313840 | 0.86 | HCAR2 (0.53) | HCAR2TDP1TSHRL3MBTL1ALDH1A1 | |
| SCHEMBL10943008 | 0.85 | KDM4E (0.43) | KDM4EHCAR2TDP1TSHRL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 495 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3266908-B1 | ANTI-BACTERIAL METALLO IONOMER POLYMER NANOCOMPOSITE FILAMENTS AND METHODS OF MAKING THE SAME | XEROX CORP (US) | 2020-05-06 | — | — | EP | claimed |
| US-10570290-B2 | Anti-bacterial aqueous ink compositions comprising metal ion composite ionomer resins | XEROX CORPORATION (US) | 2020-02-25 | — | — | US | claimed |
| EP-3266613-B1 | ANTI-BACTERIAL METALLO IONOMER POLYMER COMPOSITE POWDERS AND METHODS OF MAKING THE SAME | XEROX CORP (US) | 2019-10-16 | — | — | EP | claimed |
| US-10405540-B2 | Anti-bacterial metallo ionomer polymer nanocomposite filaments and methods of making the same | XEROX CORPORATION (US) | 2019-09-10 | — | — | US | claimed |
| US-10113059-B2 | Anti-bacterial metallo ionomer polymer nanocomposite powders and methods of making the same | XEROX CORPORATION (US) | 2018-10-30 | — | — | US | claimed |
| US-10067434-B2 | Emulsion aggregation toners | XEROX CORPORATION (US) | 2018-09-04 | — | — | US | claimed |
| US-10018930-B2 | Toner comprising colorant wax dispersion | XEROX CORPORATION (US) | 2018-07-10 | — | — | US | claimed |
| US-10018931-B2 | Toner compositions with optimized beta-carboxyethyl acrylate shell latex for improved particle formation and morphology | XEROX CORPORATION (US) | 2018-07-10 | — | — | US | claimed |
| US-10007200-B2 | Antimicrobial toner | XEROX CORPORATION (US) | 2018-06-26 | — | — | US | claimed |
| US-9989873-B1 | Toner compositions with antiplasticizers comprising purine derivative | XEROX CORPORATION (US) | 2018-06-05 | — | — | US | claimed |
| US-5827633-A | Toner processes | XEROX CORPORATION (US) | 1998-10-27 | — | — | US | claimed |
| EP-0613057-B1 | Toner processes | XEROX CORP (US) | 1998-09-16 | — | — | EP | claimed |
| US-5763133-A | Toner compositions and processes | XEROX CORPORATION (US) | 1998-06-09 | — | — | US | claimed |
| US-5747215-A | Toner compositions and processes | XEROX CORPORATION (US) | 1998-05-05 | — | — | US | claimed |
| US-5554480-A | Fluorescent toner processes | XEROX CORPORATION (US) | 1996-09-10 | — | — | US | claimed |
| US-5391456-A | Toner aggregation processes | XEROX CORPORATION (US) | 1995-02-21 | — | — | US | claimed |
| US-5370964-A | Shearing polymeric latex mixture containing surfactants; heating | XEROX CORPORATION (US) | 1994-12-06 | — | — | US | claimed |
| US-5366841-A | Toner aggregation processes | XEROX CORPORATION (US) | 1994-11-22 | — | — | US | claimed |
| US-5346797-A | Toner processes | XEROX CORPORATION (US) | 1994-09-13 | — | — | US | claimed |
| EP-0613057-A1 | Toner processes | XEROX CORPORATION (US) | 1994-08-31 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10113059-B2 | Anti-bacterial metallo ionomer polymer nanocomposite powders and methods of making the same | RPN1, RPN2, MSH2 | KDM4E 3915/4885HCAR2 4553/4885TDP1 3345/4885 |
| US-10405540-B2 | Anti-bacterial metallo ionomer polymer nanocomposite filaments and methods of making the same | TERB1, NBAS, MFAP1 | KDM4E 4082/4885HCAR2 4392/4885TDP1 2803/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.